Inhibitory effects of intravenous chloramphenicol sodium succinate on the disposition of phenylbutazone in horses
Tóm tắt
The effects of i.v. chloramphenicol sodium succinate on the pharmacokinetics of i.v. phenylbutazone in six healthy adult horses were investigated. Administration of chloramphenicol sodium succinate to mares reduced mean (±SD) phenylbutazone clearance from 0.600±0.222 to 0.339±0.123 ml/min per kg and increased mean (±SD) half life from 244 ± 59.8 to 371 ± 80.8 min and mean residence time from 333 ± 86.2 to 533 ± 124 min. The mean steady-state volume of distribution of phenylbutazone was unchanged, with mean (±SD) values of 187 ± 28.9 ml/kg in control animals and 170 ± 32.4 ml/kg after chloramphenicol sodium succinate.
Tài liệu tham khảo
H. R. Adams, E. L. Isaacson, and B. S. S. Masters. Inhibition of hepatic microsomal enzymes by chloramphenicol.J. Pharmacol. Exp. Ther. 203:388–396 (1977).
R. C. Gupta, F. Welsch, J. E. Thornburg, and B. S. Paul. Effect of chloramphenicol pretreatment on malathion-induced acute toxicity in the rat.J. Toxicol. Environ. Health 11:897–905 (1983).
H. R. Adams and B. N. Dixit. Prolongation of pentobarbital anesthesia by chloramphenicol in dogs and cats.J. Am. Vet. Med. Assoc. 156:902–905 (1970).
J. E. Sanders, R. A. Yeary, W. R. Fenner, and J. D. Powers. Interaction of phenytoin with chloramphenicol or pentobarbital in the dog.J. Am. Vet. Med. Assoc. 175:177–180 (1979).
H. R. Adams. Prolongation of barbiturate anesthesia by chloramphenicol in laboratory animals.J. Am. Vet. Med. Assoc. 157:1908–1913 (1970).
J. R. Koup, M. Gibaldi, P. McNamara, D. M. Hilligoss, W. A. Colburn, and E. Bruck. Interaction of chloramphenicol with phenytoin and phenobarbital.Clin. Pharmacol. Ther. 24: 571–575 (1978).
T. Tobin, J. W. Blake, and R. Valentine. Drug interactions in the horse: Effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.Am. J. Vet. Res. 38: 123–127 (1977).
R. L. Dixon and J. R. Fouts. Inhibition of microsomal drug metabolic pathways by chloramphenicol.Biochem. Pharmacol. 11:715–720 (1962).
A. Azadegan, D. W. Johnson, and C. M. Steve. Influence of time interval between administration of chloramphenicol and thiamylal on the sleeping time of mice.Am. J. Vet. Res. 41:976–977 (1980).
G. W. Brumbaugh, R. J. Martens, H. D. Knight, and M. T. Martin. Pharmacokinetics of chloramphenicol in the neonatal horse.J. Vet. Pharmacol. Ther. 6:219–227 (1983).
C. Metzler, G. L. Elfring and A. J. McEwan. A User's Manual for NONLIN and Associated Programs. Upjohn Co., Kalamazoo, Michigan, 1974.
K. S. Pang and J. R. Gillette. Sequential first-pass elimination of a metabolite derived from a precursor.J. Pharmacokin. Biopharm. 7:275–290 (1979).
F. C. Lam, C. T. Hung, and D. G. Perrier. Estimation of variance for harmonic mean half-lives.J. Pharm. Sci. 74:229–231 (1985).
E. J. Finocchio, F. J. Ozog, F. W. Oehme, J. H. Johnson, and G. W. Osbaldiston. Detection of phenylbutazone and oxyphenbutazone in the urine of thoroughbreds.J. Am. Vet. Med. Assoc. 156:454–456 (1970).
L. R. Soma, R. Sams, W. Duer, T. Tobin, C. Woodward, and J. McDonald. Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing thoroughbreds 24 hours after treatment with various dosage regimens.Am. J. Vet. Res. 46:932–938 (1985).
E. Jahnchen and G. Levy. Inhibition of phenylbutazone elimination by its metabolite oxyphenbutazone.Proc. Soc. Exp. Biol. Med. 141:963–965 (1972).